dronabinol has been researched along with Mental Disorders in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (23.91) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (15.22) | 29.6817 |
2010's | 22 (47.83) | 24.3611 |
2020's | 6 (13.04) | 2.80 |
Authors | Studies |
---|---|
Cousijn, J; Hoch, E; Kroon, E; Kuhns, L | 1 |
Fernández-Ruiz, J; Galve-Roperh, I; Guzmán, M; Sagredo, O | 1 |
Armatas, C; Baldwin, GT; Briss, P; Byers, P; Chatham-Stephens, K; Clark, CR; Danielson, ML; Ellington, S; Ghinai, I; Holzbauer, SM; Jones, CM; Kiernan, EA; King, BA; Koumans, EH; Krishnasamy, V; Moritz, ED; Navarette, KA; Petersen, EE; Reagan-Steiner, S; Rose, DA; Salvatore, PP; Werner, AK | 1 |
Morrison, PD; Murray, RM | 1 |
Budde, H; Coronado-Álvarez, A; Imperatori, C; Machado, S; Macías-Triana, L; Murillo-Rodríguez, E; Romero-Cordero, K; Tatum-Kuri, A; Vera-Barrón, A; Yamamoto, T | 1 |
Barry, G; Bitar, M; Brennand, KJ; Guennewig, B; Hanks, J; Hurd, YL; Kaczorowski, DC; O'Brien, EA; Obiorah, I; Roussos, P | 1 |
Friemel, CM; Hasan, A; Hoch, E; Niemann, D; Pogarell, O; Preuss, UW; Schneider, M; von Keller, R | 1 |
Lederman, IR; Morean, ME | 1 |
Jay, TM; Kebir, O; Krebs, MO | 1 |
Arbus, MS; Beliveau, JN; Casarett, DJ | 1 |
Ellison, JM; Forester, BP; Harper, DG; Stolyar, A; Woodward, MR | 1 |
Bart, Y; Eliasi, Y; Livneh, I; Monovich, E; Sagie, S | 1 |
De Bellis, MD; Hooper, SR; Woolley, D | 1 |
Bonnet, U; Borda, T; Scherbaum, N; Specka, M | 1 |
Ahmed, AIA; Feuth, T; Olde Rikkert, MGM; van den Elsen, GAH; van der Marck, MA; Verkes, RJ | 1 |
Anand, L; Furtado, M; Katzman, MA | 1 |
Bachs, L; Bramness, JG; Bretteville-Jensen, AL; Mørland, J; Vindenes, V | 1 |
Chen, DJ; Gao, FF; Gao, M; Su, QX; Wu, J | 1 |
Busquets-Garcia, A; Chaouloff, F; Ferreira, G; Mackenbach, Y; Marsicano, G; Piazza, PV; Redon, B; Soria-Gómez, E; Vallée, M; Varilh, M | 1 |
Degenhardt, L; Hall, W | 1 |
Allen, P; Atakan, Z; Bhattacharyya, S; Borgwardt, S; Crippa, JA; Fusar-Poli, P; Giampietro, V; Kapur, S; Martin-Santos, R; McGuire, PK; Mehta, MA; Morrison, PD; Murray, RM; Nosarti, C; O' Carroll, CM; Seal, M; Stone, JM; Tunstall, N; Winton-Brown, T; Zuardi, AW | 1 |
Alsindi, Z; Ambler, Z; Collin, C; Davies, P; Ehler, E; Notcutt, W; Nováková, I; O'Leary, C; Piková, J; Powell, K; Ratcliffe, S; Waberzinek, G; Zapletalova, O | 1 |
Crippa, JA; Hallak, JE; Zuardi, AW | 1 |
Henquet, C; Kuepper, R | 1 |
Bossong, MG; Jager, G; Kahn, RS; Ramsey, NF; van Hell, HH | 1 |
Bogacz, R; Jones, MW; Kucewicz, MT; Tricklebank, MD | 1 |
Psychoyos, D; Vinod, KY | 1 |
Cachope, R | 1 |
Kubota, T; Nobe, S; Watanabe, S; Yamaguchi, T; Yamamoto, T | 1 |
Manzanares, J; Palomo, T; Rubio, G; Urigüen, L | 1 |
Delile, JM | 1 |
Grech, A | 1 |
Csernansky, JG; Hollister, LE; Kanter, SL; Magliozzi, JR | 1 |
Jones, RT | 1 |
Shufman, E; Witztum, E | 1 |
Fujiwara, M | 1 |
Koukkou, M; Lehmann, D | 1 |
Melges, FT | 1 |
Lefebure, C; Nahas, GG; Zeidenberg, P | 1 |
Smith, DF | 1 |
Tunving, K | 1 |
Raulin, ML; Wert, RC | 1 |
Millman, RB; Sbriglio, R | 1 |
Chopra, GS | 1 |
Green, DE | 1 |
21 review(s) available for dronabinol and Mental Disorders
Article | Year |
---|---|
Heavy cannabis use, dependence and the brain: a clinical perspective.
Topics: Age of Onset; Brain; Causality; Cognition; Cognitive Dysfunction; Comorbidity; Dronabinol; Humans; Marijuana Abuse; Mental Disorders | 2020 |
Possible therapeutic applications of cannabis in the neuropsychopharmacology field.
Topics: Animals; Cannabinoids; Cannabis; Dronabinol; Humans; Medical Marijuana; Mental Disorders; Psychotropic Drugs | 2020 |
Psychiatric Effects of Cannabis Use.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Mental Disorders | 2020 |
Cannabis points to the synaptic pathology of mental disorders: how aberrant synaptic components disrupt the highest psychological functions
.
Topics: Animals; Cannabis; Dronabinol; Hallucinogens; Humans; Mental Disorders; Mental Processes; Receptor, Cannabinoid, CB1; Synapses | 2020 |
The synthetic CB
Topics: Analgesics; Animals; Anti-Anxiety Agents; Cannabinoid Receptor Agonists; Cannabinoids; Controlled Substances; Cyclohexanols; Dronabinol; Humans; Mental Disorders; Pain; Phenanthridines; Receptor, Cannabinoid, CB1 | 2021 |
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review.
Topics: Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Humans; Medical Marijuana; Mental Disorders | 2019 |
Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
Topics: Adolescent; Adult; Brain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Cognition Disorders; Cognitive Dysfunction; Dronabinol; Humans; Mental Disorders | 2019 |
[Short-and long-term effects of cannabinoids on memory, cognition and mental illness].
Topics: Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoids; Cognition; Dronabinol; Endocannabinoids; Humans; Memory; Mental Disorders; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Time Factors | 2013 |
Targeting the Endocannabinoid System in Psychiatric Illness.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Design; Endocannabinoids; Humans; Mental Disorders; Molecular Targeted Therapy; Research Design | 2016 |
Brain cannabinoid receptor 2: expression, function and modulation.
Topics: Animals; Brain; Cannabinoid Receptor Agonists; Dronabinol; Humans; Mental Disorders; Nervous System Diseases; Receptor, Cannabinoid, CB2 | 2017 |
Adverse health effects of non-medical cannabis use.
Topics: Accidents, Traffic; Adolescent; Adult; Cannabis; Cardiovascular Diseases; Central Nervous System; Dronabinol; Humans; Lung Diseases; Marijuana Abuse; Marijuana Smoking; Mental Disorders; Psychotropic Drugs; Young Adult | 2009 |
[Therapeutical use of the cannabinoids in psychiatry].
Topics: Animals; Cannabidiol; Dronabinol; Humans; Mental Disorders; Piperidines; Psychotropic Drugs; Pyrazoles; Rimonabant | 2010 |
Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization.
Topics: Anencephaly; Animals; Cannabinoids; Central Nervous System; Dronabinol; Drug and Narcotic Control; Female; Humans; Marijuana Abuse; Maternal Exposure; Mental Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects | 2013 |
Functional diversity on synaptic plasticity mediated by endocannabinoids.
Topics: Animals; Brain; Depression; Dronabinol; Endocannabinoids; Humans; Ligands; Mental Disorders; Neuronal Plasticity; Presynaptic Terminals; Receptor, Cannabinoid, CB1; Synaptic Transmission; Time Factors; TRPV Cation Channels | 2012 |
Role of endocannabinoid system in mental diseases.
Topics: Analgesia; Animals; Brain; Cannabinoid Receptor Modulators; Cognition Disorders; Dronabinol; Endocannabinoids; Feeding Behavior; History, 20th Century; History, 21st Century; Humans; Mental Disorders; Movement Disorders; Receptor, Cannabinoid, CB1 | 2004 |
Cannabis and health.
Topics: Abnormalities, Drug-Induced; Animals; Behavior; Cannabis; Carcinogens; Cardiovascular System; Dronabinol; Drug Interactions; Humans; Immunity; Mental Disorders; Motivation; Mutagens; Reproduction; Respiratory System; Substance Withdrawal Syndrome | 1983 |
[Characteristics of abnormal behavior induced by delta 9-tetrahydrocannabinol in rats].
Topics: Animals; Disease Models, Animal; Dronabinol; Humans; Marijuana Abuse; Mental Disorders; Mice; Rats; Receptors, Cannabinoid; Receptors, Drug; Receptors, Serotonin | 2001 |
Stereochemical considerations of the actions of some psychotropic drugs.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Central Nervous System Stimulants; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dronabinol; Humans; Lysergic Acid Diethylamide; Mental Disorders; Molecular Conformation; Psychotropic Drugs; Rats; Stereoisomerism | 1985 |
Psychiatric effects of cannabis use.
Topics: Acute Disease; Adolescent; Adolescent Behavior; Adult; Anxiety; Cerebrovascular Circulation; Chronic Disease; Cognition; Depression; Dronabinol; Electroencephalography; Female; Humans; Male; Marijuana Abuse; Mental Disorders; Middle Aged; Motivation; Personality Disorders; Psychoses, Substance-Induced; Substance Withdrawal Syndrome | 1985 |
The chronic cerebral effects of cannabis use. I. Methodological issues and neurological findings.
Topics: Atrophy; Brain; Cannabis; Cross-Cultural Comparison; Dronabinol; Electroencephalography; Humans; Marijuana Abuse; Mental Disorders; Mental Status Schedule; Neuropsychological Tests; Radiography; Research Design; Substance-Related Disorders; United States | 1986 |
Patterns of use and psychopathology in chronic marijuana users.
Topics: Adolescent; Adult; Child; Dronabinol; Humans; Male; Marijuana Abuse; Mental Disorders; Middle Aged; Motivation; United States | 1986 |
4 trial(s) available for dronabinol and Mental Disorders
Article | Year |
---|---|
Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial.
Topics: Aged; Cross-Over Studies; Dementia; Double-Blind Method; Dronabinol; Female; Humans; Male; Mental Disorders; Netherlands; Psychotropic Drugs; Treatment Outcome | 2015 |
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Topics: Acoustic Stimulation; Adult; Brain; Cannabidiol; Double-Blind Method; Dronabinol; Female; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Photic Stimulation; Psychomotor Performance; Young Adult | 2010 |
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis.
Topics: Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Plant Extracts; Severity of Illness Index; Time Factors; Treatment Outcome | 2010 |
Tracking difficulties and paranoid ideation during hashish and alcohol intoxication.
Topics: Adult; Alcoholic Intoxication; Attention; Cannabis; Clinical Trials as Topic; Dronabinol; Humans; Interpersonal Relations; Male; Memory, Short-Term; Mental Disorders; Paranoid Disorders; Self-Assessment; Time Factors | 1976 |
21 other study(ies) available for dronabinol and Mental Disorders
Article | Year |
---|---|
Hospitalizations and Deaths Associated with EVALI.
Topics: Adolescent; Adult; Aged; Asthma; Comorbidity; Dronabinol; Electronic Nicotine Delivery Systems; Female; Heart Diseases; Hospitalization; Humans; Lung Injury; Male; Mental Disorders; Middle Aged; Overweight; Patient Acuity; United States; Vaping; Young Adult | 2020 |
THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders.
Topics: Autistic Disorder; Base Sequence; Dronabinol; Gene Expression Profiling; Gene Expression Regulation; Glutamic Acid; Humans; Induced Pluripotent Stem Cells; Intellectual Disability; Mental Disorders; Mitochondria; Neurons; Post-Synaptic Density; Schizophrenia; Transcriptome | 2018 |
Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.
Topics: Adult; Cannabidiol; Chronic Pain; Dronabinol; Drug and Narcotic Control; Female; Humans; Male; Marijuana Use; Medical Marijuana; Mental Disorders; Motivation; Prevalence; Risk Factors; Sex Factors; United States; Young Adult | 2019 |
Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms.
Topics: Adolescent; Adult; Aged; Anorexia; Canada; Cannabidiol; Dronabinol; Female; Humans; Male; Mental Disorders; Middle Aged; Mobile Applications; Pain; Palliative Care; Patient Portals; Patient Satisfaction; Retrospective Studies; Sleep Initiation and Maintenance Disorders | 2019 |
Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms.
Topics: Aggression; Anorexia; Antidepressive Agents; Antipsychotic Agents; Cannabinoid Receptor Agonists; Cholinesterase Inhibitors; Cohort Studies; Dementia; Dronabinol; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Mental Disorders; Psychomotor Agitation; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2014 |
Intellectual, neurocognitive, and academic achievement in abstinent adolescents with cannabis use disorder.
Topics: Adolescent; Age of Onset; Attention; Dronabinol; Educational Status; Executive Function; Female; Humans; Illicit Drugs; Intelligence; Intelligence Tests; Male; Marijuana Abuse; Memory; Mental Disorders; Psychological Tests; Psychotropic Drugs; Remission Induction | 2014 |
Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum.
Topics: Cannabis; Comorbidity; Dronabinol; Female; Humans; Inpatients; Male; Marijuana Abuse; Mental Disorders; Prospective Studies; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 2015 |
[Does stronger cannabis cause more health problems?].
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Marijuana Abuse; Marijuana Smoking; Mental Disorders | 2016 |
Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice.
Topics: Animals; Brain; Cannabinoid Receptor Antagonists; Cannabinoids; Cannabis; Dronabinol; Male; Mental Disorders; Mice; Mice, Inbred C57BL; Pregnenolone; Psychoses, Substance-Induced; Receptor, Cannabinoid, CB1 | 2017 |
Does cannabidiol protect against the negative effects of THC?
Topics: Adolescent; Antipsychotic Agents; Cannabidiol; Dronabinol; Humans; Mental Disorders; Psychotropic Drugs | 2010 |
Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition.
Topics: Analysis of Variance; Attention; Brain; Brain Mapping; Cannabinoid Receptor Modulators; Cognition; Double-Blind Method; Dronabinol; Emotions; Endocannabinoids; Heart Rate; Humans; Image Processing, Computer-Assisted; Intelligence; Magnetic Resonance Imaging; Mental Disorders; Neuropsychological Tests; Oxygen; Pain Measurement; Personality; Psychotropic Drugs; Randomized Controlled Trials as Topic; Reward; Spin Labels; Time Factors | 2011 |
Dysfunctional prefrontal cortical network activity and interactions following cannabinoid receptor activation.
Topics: Action Potentials; Analysis of Variance; Animals; Biological Clocks; Brain Waves; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Confidence Intervals; Cyclohexanols; Dronabinol; Electric Stimulation; Evoked Potentials; Hippocampus; Immunosuppressive Agents; Male; Maze Learning; Memory, Short-Term; Mental Disorders; Nerve Net; Neurons; Prefrontal Cortex; Rats; Rats, Long-Evans; Reaction Time; Receptors, Cannabinoid; Statistics, Nonparametric; Time Factors | 2011 |
[Role of brain prostaglandin biosynthesis in behavioral disorders induced by tetrahydrocannabinol in marihuana].
Topics: Animals; Arachidonic Acid; Brain; Cannabis; Dinoprostone; Dose-Response Relationship, Drug; Dronabinol; Male; Mental Disorders; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug | 2002 |
[Use of cannabis: screening strategy and evaluation of severity factors].
Topics: Acute Disease; Adolescent; Age Factors; Automobile Driving; Dronabinol; Family; Family Practice; Female; France; Hair; Health Policy; Humans; Male; Marijuana Abuse; Mental Disorders; Pregnancy; Prognosis; Psychopathology; Risk Factors; Surveys and Questionnaires | 2005 |
Should we advise patients with serious mental illness to stop using cannabis?
Topics: Attitude of Health Personnel; Attitude to Health; Comorbidity; Counseling; Diagnosis, Dual (Psychiatry); Dronabinol; Humans; Marijuana Abuse; Mental Disorders; Psychiatry; Psychotic Disorders; Schizophrenia | 2008 |
Detection of marijuana use in psychiatric patients by determination of urinary delta-9-tetrahydrocannabinol-11-oic acid.
Topics: Adult; Dronabinol; Hospitalization; Humans; Male; Marijuana Abuse; Mental Disorders; Time Factors | 1983 |
[Cannabis--a drug with dangerous implications for mental health].
Topics: Cannabis; Dronabinol; Humans; Marijuana Abuse; Mental Disorders; Mental Health; Psychotic Disorders; Psychotropic Drugs | 2000 |
Correlations between cannabis-induced psychopathology and EEG before and after drug ingestion.
Topics: Adult; Body Image; Body Weight; Cannabis; Dronabinol; Electroencephalography; Euphoria; Female; Hallucinogens; Humans; Male; Mental Disorders; Surveys and Questionnaires | 1978 |
Kif in Morocco.
Topics: Agriculture; Cannabis; Chronic Disease; Commerce; Culture; Dronabinol; Drug and Narcotic Control; Economics; Female; History, 20th Century; History, Ancient; Humans; Legislation as Topic; Male; Mental Disorders; Minority Groups; Morocco; Substance-Related Disorders; Tuberculosis, Pulmonary | 1975 |
Studies on psycho-clinical aspects of long-term marihuana use in 124 cases.
Topics: Adult; Appetite; Attitude; Cannabis; Chemical and Drug Induced Liver Injury; Chronic Disease; Cognition Disorders; Dronabinol; Emotions; Humans; Inhibition, Psychological; Mental Disorders; Motivation; Movement Disorders; Nutrition Disorders; Phytotherapy; Respiratory System; Sexual Behavior; Social Behavior; Space Perception; Substance-Related Disorders; Tachycardia; Thinking; Time Factors; Time Perception | 1973 |
Direct, multiple ion detection of chlorpromazine by mass fragmentography.
Topics: Chlorpromazine; Chromatography, Gas; Computers; Dronabinol; Humans; Hydroxylation; Mass Spectrometry; Mental Disorders; Methods | 1974 |